Laverdia, a new oral treatment for Canine Lymphoma

**Click Here to Register**

Approved for one hour California Statutory CEU

SPEAKER: Dave Bruyette, DVM, DACVIM

Dr. David Bruyette received his Doctor of Veterinary Medicine degree from the University of Missouri. Subsequently, he completed an internship at Purdue University and residency in internal medicine at the University of California-Davis. He was a staff internist at the West Los Angeles Veterinary Medical Group and a member of the Department of Comparative Medicine at Stanford University. Dr. Bruyette was an Assistant Professor and Head of Internal Medicine at Kansas State University and Director of the Analytical Chemistry Laboratory at Kansas State. He was Medical Director of the VCA West Los Angeles Animal Hospital, one of the largest 24-hour emergency/specialty practices in the country from Sept 1996 – Jan 2017. Dr. Bruyette is a diplomate of the American College of Veterinary Internal Medicine and a member of the Endocrine Society.

Currently he is the Chief Medical Officer for Anivive Lifesciences. Anivive is engaged in drug discovery to find new pharmaceuticals for use in dogs and cats.